Assignee
DOV PHARMACEUTICAL INC
US·8 granted patents·3 pending applications·301 citations·filing 1998–2007
Top patents by PatentIndex Score
11 records- 0196US6372919B1(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agentDOV PHARMACEUTICAL INC·Filed 2001·Granted Apr 16, 2002·87 cites·15 claims
- 0294US6716868B2(-)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2003·Granted Apr 6, 2004·41 cites·3 claims
- 0390US7098229B2(+)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions and uses thereofDOV PHARMACEUTICAL INC·Filed 2002·Granted Aug 29, 2006·32 cites·18 claims
- 0490US7081471B2(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted Jul 25, 2006·24 cites·4 claims
- 0589US7098230B2(-)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted Aug 29, 2006·20 cites·23 claims
- 0689US7041835B2(−)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as a dopamine-reuptake inhibitorDOV PHARMACEUTICAL INC·Filed 2004·Granted May 9, 2006·23 cites·10 claims
- 0783US7094799B2Polymorphs of bicifadine hydrochlorideDOV PHARMACEUTICAL INC·Filed 2003·Granted Aug 22, 2006·28 cites·5 claims
- 0876US6162463AExtended release formulation of diltiazem hydrochlorideDOV PHARMACEUTICAL INC·Filed 1998·Granted Dec 19, 2000·46 cites·16 claims
- 0959US2007149599A1Polymorphs of bicifadine hydrochlorideDOV PHARMACEUTICAL INC·Filed 2007·Application pending·0 cites
- 1055US2007082938A1Polymorphs of bicifadine hydrochlorideDOV PHARMACEUTICAL INC·Filed 2006·Application pending·0 cites
- 1147US2002172694A1Extended release formulation of diltiazem hydrochlorideDOV PHARMACEUTICAL INC·Filed 2001·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →